Paul Goldsmith
8Patents
1h-index
15Co-inventors
48Inventor score
Filing activity: Jan 14, 2000 → Dec 4, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6974698B1 | Methods for delivering biologically active molecules into cells | Chemistry; Metallurgy | 18 | Expired |
| US8247183B2 | Compositions and methods for diagnosis and treatment of tumors | Physics | 1 | Active |
| US8658683B2 | Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea | Human Necessities | 0 | Active |
| US12420014B2 | Dosing of incretin pathway drugs | Human Necessities | 0 | Active |
| US8481583B2 | Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea | Human Necessities | 0 | Active |
| US11710547B2 | Methods and systems for providing personalised medicine to a patient | Human Necessities | 0 | Active |
| US12295943B2 | Apixaban dosing | Physics | 0 | Active |
| US8568977B2 | Compositions and methods for diagnosis and treatment of tumors | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.